MP56: Bladder Cancer: Invasive V

Monday, May 16, 2022

10:30 AM – 11:45 AM

Location: Room 228

Poster Session Moderator(s)

Brant Inman, MD, MS, FRCSC

Duke Cancer Institute
Matthew Tollefson

Mayo Clinic

Podium Session Moderator(s)

Robert Svatek, MD (he/him/his)

Professor and Chair
University of Texas Health San Antonio (UTHSA)

Presentations:

10:30 AM – 11:45 AM

MP56-01: Renal Functional Changes after Cystectomy: Who Improves and Who Does Not?
Poster Presenter: Benjamin J. Croll, MD – Emory University School of Medicine
10:30 AM – 11:45 AM

MP56-02: Neoadjuvant pembrolizumab may result in long-term outcome improvement in biomarker-unselected patients with muscle-invasive bladder cancer (MIBC): Updated results from PURE-01
Poster Presenter: Luigi Nocera – IRCCS Ospedale San Raffaele
10:30 AM – 11:45 AM

MP56-03: Clinical Outcomes and Surgical Management of Urachal Carcinoma: An analysis of the National Cancer Database
Poster Presenter: Kelvin Lim, BS
10:30 AM – 11:45 AM

MP56-04: The role of FDG PET in the staging of bladder cancer patients candidate for radical cystectomy
Poster Presenter: Luigi Nocera – IRCCS Ospedale San Raffaele
10:30 AM – 11:45 AM

MP56-05: Impact of comprehensive measurement of Surgical Outcomes on Subjective assessment of Health Related Quality of Life in patients receiving Radical Cystectomy with orthotopic Padua Ileal Bladder: single center randomized controlled trial
Poster Presenter: Riccardo Mastroianni, MD
10:30 AM – 11:45 AM

MP56-06: Associations between Skeletal Muscle Gauge and Survival Following Radical Cystectomy for Bladder Cancer: A Novel Assessment of Muscle Mass and Quality
Poster Presenter: Meghana Noonavath, BS
10:30 AM – 11:45 AM

MP56-07: Predictors of response following neoadjuvant cisplatin based chemotherapy for muscle invasive urothelial bladder cancer using molecular profile
Poster Presenter: Ahmed Elsherbiny Elkarta, MD, MBBS – Mansoura Urology & Nephrology Center
10:30 AM – 11:45 AM

MP56-08: Clinicopathologic and Survival After Cystectomy Outcomes in Squamous Cell Carcinoma of the Bladder
Poster Presenter: Pranjal Agrawal, BA
10:30 AM – 11:45 AM

MP56-09: Radiomics-based deep-learning improves CT-staging of lymph node status for bladder cancer patients
Poster Presenter: Gerald Bastian Schulz, MD,FEBU – Department of Urology, LMU Munich
10:30 AM – 11:45 AM

MP56-10: Characterization and functional analysis of microbiome in bladder cancer.
Poster Presenter: Laura Bukavina, MD, MPH
10:30 AM – 11:45 AM

MP56-11: The Association Between Early Post-Radical Cystectomy Acute Kidney Injury And Perioperative Outcome In Enhanced Recovery Era
Poster Presenter: Sina Sobhani, BS
10:30 AM – 11:45 AM

MP56-12: Upper Tract Recurrence Risk based on Drainage Method for Ureteral Obstruction prior to Radical Cystectomy
Poster Presenter: Wesley Yip, MD
10:30 AM – 11:45 AM

MP56-13: Role of radical cystectomy and lymph node dissection in patients with non-metastatic clinically advanced lymph nodal (cN2/N3) bladder cancer: An analysis from National Cancer Database
Poster Presenter: Harshit Garg, MD – University of Texas Health, San Antonio
10:30 AM – 11:45 AM

MP56-14: Utilizing the Modified Frailty Index to Predict Outcomes after Radical Cystectomy
Poster Presenter: Hannah Jarvis, MD
10:30 AM – 11:45 AM

MP56-15: Perioperative Outcomes of Patients Undergoing Concurrent Nephroureterectomy and Cystectomy for Urothelial Cancer: An NSQIP Database Analysis
Poster Presenter: Pratik Kanabur, MD, BS
10:30 AM – 11:45 AM

MP56-16: Surgical Management of Clinically Localized Urachal Carcinoma: Evaluating the Role of Lymphadenectomy as Standard of Care
Poster Presenter: Kyle M. Rose, MD,MS
10:30 AM – 11:45 AM

MP56-17: Radical cystectomy video consensus: a simple and effective way to improve awareness of patients undergoing radical cystectomy
Poster Presenter: Francesco Prata, MD
10:30 AM – 11:45 AM

MP56-18: Prevalence and predictors of psychological distress among patients treated for bladder cancer
Poster Presenter: Nihal Mohamed, PhD – Mount Sinai School of Med
10:30 AM – 11:45 AM

MP56-19: Trimodal therapy versus radical cystectomy for T2 bladder cancer: real-world evidence from Ontario
Poster Presenter: Marian Severin Wettstein, MD PhD (he/him/his) – University Health Network
10:30 AM – 11:45 AM

MP56-20: Surrogate endpoints as predictors of survival in metastatic urothelial cancer trials
Poster Presenter: Fady Ghali, MD – University of Washington, Department of Urology